Created in 2013 (United States), REPATHA own
142 sister brands
and 17478 competing brands.
REPATHA is a brand of Amgen, listed on the stock exchange of New York.
REPATHA belongs to the Drug Manufacturers business sector.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.